-
Shenqi Fuzheng Targets Glioma via SRC/PI3K/AKT
2026-08-28
This study integrates network pharmacology with cellular and animal experiments to investigate how Shenqi Fuzheng injection affects glioma proliferation and migration. Its results implicate SRC/PI3K/AKT signaling while providing a practical framework for connecting predicted multi-target activity with cell-cycle, epithelial–mesenchymal transition, and tumor-growth readouts.
-
Safe DNA Gel Stain: From Signal to Confidence
2026-08-28
A thought-leadership perspective on how safer nucleic acid visualization can strengthen experimental fidelity, cloning workflows, and translational decision-making. The article connects fluorescence chemistry, gel-imaging strategy, and lessons from enzyme-engineered starch research without overstating cross-domain evidence.
-
EdU Cell Proliferation Kit for RA S-Phase Studies
2026-08-27
The EdU Cell Proliferation Kit (TMB) converts DNA synthesis into a sensitive, non-radioactive absorbance readout for rheumatoid arthritis fibroblast-like synoviocytes and drug-response studies. Its click-chemistry workflow helps connect ARL4C biology with practical cell proliferation measurement, genotoxicity testing, and pharmacodynamic drug evaluation.
-
Q-VD-OPh in Caspase-Driven Viral Secretion
2026-08-27
Q-VD-OPh is a cell-permeable pan-caspase inhibitor that can do more than suppress apoptosis. This article explains how to use it as a causal probe for distinguishing caspase-dependent viral protein secretion, NINJ1-mediated membrane rupture, and nonspecific cellular damage.
-
Purmorphamine: Smoothened Agonist Workflows
2026-08-26
Purmorphamine is a practical Smoothened agonist for connecting Hedgehog pathway activation with osteoblast differentiation, mesenchymal stem cell responses, and sensory biology. This workflow-focused guide covers dose design, orthogonal readouts, handling, and the limitations of translating findings between mammalian and insect models.
-
Dextrose in Hypoxic Immunometabolism Research
2026-08-26
Dextrose (D-glucose) is more than a routine nutrient: it is a controllable variable for studying nutrient competition, glycolytic adaptation, and immune dysfunction in hypoxic tumor models. This guide translates recent immunometabolism insights into practical assay-design decisions.
-
3D Tumor Spheroid Assay for Glioblastoma Stemness
2026-08-25
Chen and colleagues describe a streamlined 96-well 3D tumor spheroid assay for functionally assessing stem-like behavior in glioblastoma cell lines. The protocol reduces the time and handling associated with earlier two-round sphere-forming workflows while preserving a practical readout for stemness-related experiments and therapeutic screening.
-
N4-Acetylcytidine for Reliable RNA Assays
2026-08-25
Learn how N4-Acetylcytidine, SKU C6648, can improve the interpretability of RNA modification, enzyme, and cell-response workflows. This scenario-based guide covers formulation, controls, storage, data interpretation, and practical vendor selection.
-
Excessive Calpain and Offspring Cognition After Surgery
2026-08-24
A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy to excessive calpain activity, impaired hippocampal BDNF/TrkB signaling, and cognitive deficits in rat offspring. Pharmacological rescue with MDL 28170 or the TrkB agonist 7,8-DHF partially restored synaptic and behavioral outcomes, identifying calpain-dependent signaling as a mechanistic target for neurodevelopmental research.
-
Mitomycin C: From DNA Damage to Immune Strategy
2026-08-24
Mitomycin C is more than a cytotoxic reagent: its covalent DNA damage and TRAIL-sensitizing activity create a platform for testing how tumor-cell death intersects with immune clearance. This article connects established apoptosis signaling research with the Notch1–YY1–ICAM1 findings in hepatocellular carcinoma while defining the evidence boundaries for translational combination studies.
-
Cas9 mRNA–gRNA Editing of LGMN in Breast Cancer
2026-08-23
The reference study developed a lipid nanoparticle strategy for co-delivering Cas9 mRNA and guide RNAs to disrupt LGMN, a metastasis-associated lysosomal protease gene. Its results connect transient CRISPR component delivery with impaired lysosomal/autophagic degradation and reduced breast cancer cell migration, invasion, and experimental lung metastasis.
-
Liraglutide and the Brain-Kidney AVP Axis
2026-08-22
Greenwood and colleagues connect liraglutide treatment with reduced circulating arginine vasopressin (AVP) in healthy humans and identify time- and sex-dependent synaptic phosphorylation changes in the rat pituitary. Their combined clinical, proteomic, reporter-assay, and renal analyses suggest that altered AVP release and aquaporin 2 regulation may contribute to the diuretic and natriuretic effects of GLP-1 receptor agonists.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-22
Peramangalam et al. identify an enhancer-dependent MYCN program and its downstream effector eIF4G1 as essential components of survival in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC-associated transcriptional disruption to a therapeutically relevant N-MYC/eIF4G1 dependency using transcriptomic, chromatin, genetic, primary-cell, and patient-derived xenograft models.
-
Vidarabine Monohydrate: Antiviral Research Guide
2026-08-21
Vidarabine monohydrate is a purine nucleoside analog used to study inhibition of viral DNA synthesis and DNA replication interference. The C6377 product is supplied at ≥98% purity, is reported as DMSO-soluble but insoluble in water and ethanol, and is intended for research use only.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-20
This 2025 review integrates tumor hypoxia, metabolic reprogramming, nutrient competition, and immune dysfunction into a unified model of immunosuppressive tumor microenvironment formation. Its main practical value is to connect oxygen-regulated metabolism with immune-cell state, while emphasizing that metabolism-based therapies and biomarkers remain highly context dependent.